Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1017/S0033291721005122 | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background Deficits in emotional intelligence (EI) were detected in patients with bipolar disorder (BD), but little is known about whether these deficits are already present in patients after presenting a first episode mania (FEM). We sought (i) to compare EI in patients after a FEM, chronic BD and healthy controls (HC); (ii) to examine the effect exerted on EI by socio-demographic, clinical and neurocognitive variables in FEM patients. Methods The Emotional Intelligence Quotient (EIQ) was calculated with the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Performance on MSCEIT was compared among the three groups using generalized linear models. In patients after a FEM, the influence of socio-demographic, clinical and neurocognitive variables on the EIQ was examined using a linear regression model. Results In total, 184 subjects were included (FEM n = 48, euthymic chronic BD type I n = 75, HC n = 61). BD patients performed significantly worse than HC on the EIQ [mean difference (MD) = 10.09, standard error (s.e.) = 3.14, p = 0.004] and on the understanding emotions branch (MD = 7.46, s.e. = 2.53, p = 0.010). FEM patients did not differ from HC and BD on other measures of MSCEIT. In patients after a FEM, EIQ was positively associated with female sex (beta = -0.293, p = 0.034) and verbal memory performance (beta = 0.374, p = 0.008). FEM patients performed worse than HC but better than BD on few neurocognitive domains. Conclusions Patients after a FEM showed preserved EI, while patients in later stages of BD presented lower EIQ, suggesting that impairments in EI might result from the burden of disease and neurocognitive decline, associated with the chronicity of the illness.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Varo, Cristina | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 2 | Amoretti, Silvia | Mujer |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Univ Barcelona - España Vall dHebron Res Inst VHIR - España Hosp Univ Vall dHebron - España Universitat de Barcelona - España Hospital Universitari Vall d'Hebron - España Centro de Investigación Biomédica En Red de Salud Mental - España Vall d'Hebron Institut de Recerca - España |
| 3 | Sparacino, G. | Hombre |
Univ Milan - Italia
Centro de Investigación Biomédica En Red de Salud Mental - España Università degli Studi di Milano - Italia |
| 4 | Jimenez, Esther | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 5 | Sole, Brisa | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Vall d'Hebron Institut de Recerca - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 6 | Bonnin, Caterina del Mar | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 6 | Mar Bonnin, Caterina Del | Mujer |
Universitat de Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España |
| 7 | Montejo, Laura | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Hospital Universitari Vall d'Hebron - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 8 | Pomarol-Clotet, Edith | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España FIDMAG Germanes Hosp Res Fdn - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España FIDMAG Germanes Hospitalàries Research Foundation - España |
| 9 | Torrent, C. | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Università degli Studi di Milano - Italia Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 10 | Salagre, Estela | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España FIDMAG Germanes Hospitalàries Research Foundation - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 11 | Benabarre, Antoni | Hombre |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 12 | Salgado-Pineda, Pilar | Mujer |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
FIDMAG Germanes Hosp Res Fdn - España Institut Pere Mata - España Centro de Investigación Biomédica En Red de Salud Mental - España FIDMAG Germanes Hospitalàries Research Foundation - España |
| 13 | Montoro Salvatierra, Irene | Mujer |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Univ Rovira & Virgili - España Universidad de Oviedo - España Centro de Investigación Biomédica En Red de Salud Mental - España Institut Pere Mata - España |
| 14 | Saiz, Pilar A. | Mujer |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Univ Oviedo - España Universitat Autònoma de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España Universidad de Oviedo - España |
| 15 | Paz Garcia-Portilla, Maria | - |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Univ Oviedo - España Centro de Investigación Biomédica En Red de Salud Mental - España Universidad de Oviedo - España |
| 15 | García-Portilla, Maria Paz | Mujer |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Univ Oviedo - España Universitat Autònoma de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España Universidad de Oviedo - España |
| 16 | Sanchez Gistau, Vanessa | Mujer |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Univ Rovira & Virgili - España Universidad del Desarrollo - Chile Centro de Investigación Biomédica En Red de Salud Mental - España Institut Pere Mata - España |
| 17 | Pomarol-Clotet, Edith | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España FIDMAG Germanes Hosp Res Fdn - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España FIDMAG Germanes Hospitalàries Research Foundation - España |
| 18 | Ramos-Quiroga, Josep Antoni | Hombre |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Vall dHebron Res Inst VHIR - España Hosp Univ Vall dHebron - España UNIV AUTONOMA BARCELONA - España Instituto Psiquiátrico Dr. José Horwitz Barak - Chile Hospital Universitari Vall d'Hebron - España Centro de Investigación Biomédica En Red de Salud Mental - España Vall d'Hebron Institut de Recerca - España Universitat Autònoma de Barcelona - España |
| 18 | Antoni Ramos-Quiroga, Josep | - |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Vall dHebron Res Inst VHIR - España Hosp Univ Vall dHebron - España UNIV AUTONOMA BARCELONA - España Centro de Investigación Biomédica En Red de Salud Mental - España Vall d'Hebron Institut de Recerca - España Hospital Universitari Vall d'Hebron - España Universitat Autònoma de Barcelona - España |
| 19 | Pacchiarotti, Isabella | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 20 | Garcia-Rizo, Clemente | Hombre |
Biomed Res Networking Ctr Mental Hlth Network Cib - España
Univ Barcelona - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 21 | UNDURRAGA-FOURCADE, JUAN PABLO | Hombre |
Universidad del Desarrollo - Chile
Inst Psiquiatr Dr J Horwitz Barak - Chile Universitat de Barcelona - España Instituto Psiquiatrico - Chile |
| 22 | Reinares, Maria | Mujer |
Univ Barcelona - España
Universitat de Barcelona - España |
| 23 | Martinez Aran, Anabel | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 24 | Vieta, E. | Hombre |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| 25 | Verdolini, Norma | Mujer |
Univ Barcelona - España
Biomed Res Networking Ctr Mental Hlth Network Cib - España Universitat de Barcelona - España Centro de Investigación Biomédica En Red de Salud Mental - España |
| Fuente |
|---|
| Spanish Ministry of Science and Innovation |
| Ministerio de Economía y Competitividad |
| European Regional Development Fund |
| Ministerio de Ciencia e Innovación |
| European Social Fund |
| Instituto de Salud Carlos III |
| Ministerio de Ciencia, Innovacion y Universidades |
| Horizon 2020 |
| CERCA Programme/Generalitat de Catalunya |
| Clinica Alemana de Santiago |
| Centro de Investigación Biomédica en Red de Salud Mental |
| Marie Sklodowska-Curie |
| Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement |
| 'la Caixa' Foundation |
| ISCIII-Subdirección |
| ANID-Fondecyt |
| CIBER of Mental Health (CIBERSAM) |
| Fondo Europeo de Desarrollo Regional (FEDER) - European Social Fund 'Investing in your future' |
| FIS grants |
| ISCIII-Subdireccion General de Evaluacion - European Social Fund 'Investing in your future' |
| Spanish Ministry of Science, Innovation and Universities integrated into the Plan Nacional de I + D + I |
| PERIS projects |
| BITRECS project from the European Union's Horizon 2020 research and innovation program under the Marie Skodowska-Curie grant |
| Pla estrategic de Recerca i Innovacio en Salut 2016–2020 |
| Agradecimiento |
|---|
| The authors would like to thank the support of the Spanish Ministry of Science and Innovation; the CIBER of Mental Health (CIBERSAM); the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2017 SGR 1365; 2017-SGR-1271) and the CERCA Programme/Generalitat de Catalunya. This work has been also supported by the Spanish Ministry of Science, Innovation and Universities integrated into the Plan Nacional de I + D + I y cofinanciado por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) through a 'Miguel Servet' postdoctoral contract (CPI14/00175 to CT), a Miguel Servet II contract (CPII19/00018 to CT, CPII16/00018 to EP-C), a 'Ro Hortega' contract (CM19/00123 to ES), a 'Sara Borrell' (CD20/00177 to SA), both co-funded by European Social Fund 'Investing in your future', and the FIS grants (PI15/00283 and PI18/00805 to EV, PI15/00330 and PI18/00789 to AMA, PI18/01001 to IP). This work has been also supported by the PERIS projects SLT006/17/00357 and SLT006/17/00345 in the 'Pla estrategic de Recerca i Innovacio en Salut 2016-2020' (Health Department) and by the BITRECS project to NV, which has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Skodowska-Curie grant agreement No 754550 and from 'La Caixa' Foundation (ID 100010434), under the agreement LCF/PR/GN18/50310006. In addition, it has been supported by ANID-PIA-ACT192064, ANID-FONDECYT 1180358, 1200601, Clinica Alemana de Santiago ID 863 to Juan Undurraga. The authors are extremely grateful to all the participants. |
| EV has received grants and served as consultant, advisor, or CME speaker for the following entities (unrelated to the present work): AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis, and Takeda. AMA has received funding for research projects and/or honoraria as a consultant or speaker for the following companies and institutions (work unrelated to the topic of this manuscript): Otsuka, Pfizer, AstraZeneca, Bristol-Myers Squibb, Lundbeck, the Spanish Ministry of Economy and Competitiveness, and Instituto de Salud Carlos III. AB has received grants and served as a consultant, advisor, or CME speaker for the following entities in the last 5 years (unrelated to the present work): Janssen, Lundbeck, Otsuka, and Pfizer. PAS has been a consultant to and/or has received honoraria or grants from Adamed, CIBERSAM, European Commission, Government of the Principality of Asturias, Instituto de Salud Carlos III, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Plan Nacional sobre Drogas, and Servier. MPGP has been a consultant to and/or has received honoraria/grants from Angelini, Alianza Otsuka-Lundbeck, Instituto de Salud Carlos III, Janssen-Cilag, Lundbeck, Otsuka, Pfizer, and SAGE Therapeutics. IP has received CME-related honoraria, or consulting fees from ADAMED, Janssen-Cilag, and Lundbeck. CGR has received honoraria/travel support from Angelini, Adamed, Janssen-Cilag, and Lundbeck. NV has received financial support for CME activities and travel funds from the following entities (unrelated to the present work): Angelini, Janssen, Lundbeck, Otsuka. The rest of authors report no biomedical financial interests or potential conflicts of interest related to the present article. |